Resistance to thyroid hormone in a patient with coexisting Graves' disease.

Article Details

Citation

Sivakumar T, Chaidarun S

Resistance to thyroid hormone in a patient with coexisting Graves' disease.

Thyroid. 2010 Feb;20(2):213-6. doi: 10.1089/thy.2009.0175.

PubMed ID
20151830 [ View in PubMed
]
Abstract

BACKGROUND: Resistance to thyroid hormone (RTH) is a rare disorder in which an abnormality in the binding domain of the thyroid hormone receptor results in end-organ insensitivity to the actions of thyroid hormones. This disorder is sometimes misdiagnosed as Graves' disease due to the presence of a goiter with high Iodine-123 thyroid uptake and high levels of total and free thyroid hormones. Additionally, some patients with RTH may experience palpitations or tachycardia. There is a previous report of a patient with pituitary RTH and concurrent Graves' disease. SUMMARY: We describe a patient who was found to have a goiter with signs and symptoms of hyperthyroidism by his primary care physician. Work-up revealed a low thyroid stimulating hormone (TSH), high thyroid-stimulating immunoglobulins, high Iodine-123 thyroid uptake, as well as increased homogenous activity in both thyroid glands on nuclear scan and a suppressed TSH. Diagnosis of Graves' disease was made, and the patient underwent radioactive ablation of the thyroid gland. The patient subsequently developed hypothyroidism and required a much higher dose of levothyroxine than his weight-based estimate of a full replacement dose to maintain euthyroidism. On 325 micog of daily levothyroxine the patient was clinically euthyroid and had a normal TSH although his levels of T3 and T4 were high. Work-up revealed a mutation in the thyroid hormone beta-receptor gene, consistent with diagnosis of RTH. CONCLUSIONS: RTH is often misdiagnosed as Graves' disease. However, these disorders can coexist, and the concurrent presence of both disorders in a patient can present diagnostic challenges. A previous report of a patient with Graves' disease associated with RTH was published before gene sequencing could be used to confirm diagnosis of RTH. We present a patient with Graves' disease and concurrent RTH that was confirmed by gene sequencing, showing a mutation in the thyroid hormone receptor beta gene.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
LevothyroxineThyroid hormone receptor betaProteinHumans
Yes
Agonist
Details
LiotrixThyroid hormone receptor betaProteinHumans
Yes
Agonist
Details